4//SEC Filing
Saadi Ryan H. 4
Accession 0001062993-24-012192
CIK 0001860871other
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 4:29 PM ET
Size
5.8 KB
Accession
0001062993-24-012192
Insider Transaction Report
Form 4
Saadi Ryan H.
DirectorChief Executive Officer10% Owner
Transactions
- Purchase
Common Stock
2024-06-05$0.77/sh+2,607.322$2,000→ 118,252,659.322 total
Holdings
- 193,924(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]The price reported in Column 4 represents a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.7635 to $0.7671, inclusive. The reporting person undertakes to provide to Tevogen Bio Holdings Inc., any security holder of Tevogen Bio Holdings Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
Issuer
Tevogen Bio Holdings Inc.
CIK 0001860871
Entity typeother
Related Parties
1- filerCIK 0002011728
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 4:29 PM ET
- Size
- 5.8 KB